These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1956910)

  • 21. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
    Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
    Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.
    Eichelbaum M; Baur MP; Dengler HJ; Osikowska-Evers BO; Tieves G; Zekorn C; Rittner C
    Br J Clin Pharmacol; 1987 Apr; 23(4):455-8. PubMed ID: 3472585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of human cytochrome P-450 enzymes in the metabolism of xenobiotics].
    Monostory K; Vereczkey L
    Acta Pharm Hung; 1995 Sep; 65(5):147-56. PubMed ID: 7484161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The excessive activity of cytochrome P450 system in ALS--the metabolic ratio of sparteine].
    Kaneko K; Atsumi T; Miyataka T
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1251-5. PubMed ID: 2605831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The debrisoquine/sparteine oxidation polymorphism: evidence of genetic heterogeneity among Ghanaians.
    Woolhouse NM
    Prog Clin Biol Res; 1986; 214():189-206. PubMed ID: 3725761
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of cytochrome P450 polymorphisms.
    Daly AK; Monkman SC; Smart J; Steward A; Cholerton S
    Methods Mol Biol; 1998; 107():405-22. PubMed ID: 14577249
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
    Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
    Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic variations in the metabolism of environmental toxins].
    Autrup H
    Ugeskr Laeger; 2005 May; 167(20):2173-6. PubMed ID: 15987077
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
    Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y
    Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmocogenetic implications of polymorphic debrisoquine hydroxylations.
    Rawlins MD
    Q J Med; 1985 Feb; 54(214):115-6. PubMed ID: 3983355
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitro.
    Tyndale RF; Inaba T; Kalow W
    Drug Metab Dispos; 1989; 17(3):334-40. PubMed ID: 2568917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
    Ebner T; Meese CO; Eichelbaum M
    Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation.
    Gonzalez FJ; Nebert DW
    Trends Genet; 1990 Jun; 6(6):182-6. PubMed ID: 2196721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytochromes P450: evolution and cDNA-directed expression.
    Gonzalez FJ; Gelboin HV
    Environ Health Perspect; 1992 Nov; 98():81-5. PubMed ID: 1486867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human P-450 genes: evolution, regulation and possible role in carcinogenesis.
    Nebert DW; Jaiswal AK; Meyer UA; Gonzalez FJ
    Biochem Soc Trans; 1987 Aug; 15(4):586-9. PubMed ID: 3678581
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacogenetics: Part I.
    Gibaldi M
    Ann Pharmacother; 1992 Jan; 26(1):121-6. PubMed ID: 1606333
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility.
    Gonzalez FJ
    Reprod Toxicol; 1997; 11(2-3):397-412. PubMed ID: 9100315
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.
    Guengerich FP; Shimada T
    Chem Res Toxicol; 1991; 4(4):391-407. PubMed ID: 1912325
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacogenetics of cytochromes P450: practical implications].
    Jaillon P
    Arch Pediatr; 2001 May; 8 Suppl 2():350s-352s. PubMed ID: 11394113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.